Drug hypersensitivity reactions involving skin
- PMID: 20020258
- DOI: 10.1007/978-3-642-00663-0_2
Drug hypersensitivity reactions involving skin
Abstract
Immune reactions to drugs can cause a variety of diseases involving the skin, liver, kidney, lungs, and other organs. Beside immediate, IgE-mediated reactions of varying degrees (urticaria to anaphylactic shock), many drug hypersensitivity reactions appear delayed, namely hours to days after starting drug treatment, showing a variety of clinical manifestations from solely skin involvement to fulminant systemic diseases which may be fatal. Immunohistochemical and functional studies of drug-specific T cells in patients with delayed reactions confirmed a predominant role for T cells in the onset and maintenance of immune-mediated delayed drug hypersensitivity reactions (type IV reactions). In these reactions, drug-specific CD4+ and CD8+ T cells are stimulated by drugs through their T cell receptors (TCR). Drugs can stimulate T cells in two ways: they can act as haptens and bind covalently to larger protein structures (hapten-carrier model), inducing a specific immune response. In addition, they may accidentally bind in a labile, noncovalent way to a particular TCR of the whole TCR repertoire and possibly also major histocompatibility complex (MHC)-molecules - similar to their pharmacologic action. This seems to be sufficient to reactivate certain, probably in vivo preactivated T cells, if an additional interaction of the drug-stimulated TCR with MHC molecules occurs. The mechanism was named pharmacological interaction of a drug with (immune) receptor and thus termed the p-i concept. This new concept may explain the frequent skin symptoms in drug hypersensitivity to oral or parenteral drugs. Furthermore, the various clinical manifestations of T cell-mediated drug hypersensitivity may be explained by distinct T cell functions leading to different clinical phenotypes. These data allowed a subclassification of the delayed hypersensitivity reactions (type IV) into T cell reactions which, by releasing certain cytokines and chemokines, preferentially activate and recruit monocytes (type IVa), eosinophils (type IVb), or neutrophils (type IVd).
Similar articles
-
Drug hypersensitivity reactions: pathomechanism and clinical symptoms.Med Clin North Am. 2010 Jul;94(4):645-64, xv. doi: 10.1016/j.mcna.2010.04.003. Med Clin North Am. 2010. PMID: 20609855 Review.
-
Role of T cells in nonimmediate allergic drug reactions.Curr Opin Allergy Clin Immunol. 2009 Aug;9(4):305-10. doi: 10.1097/ACI.0b013e32832d565c. Curr Opin Allergy Clin Immunol. 2009. PMID: 19474707 Review.
-
Delayed drug hypersensitivity reactions - new concepts.Clin Exp Allergy. 2007 Jul;37(7):989-99. doi: 10.1111/j.1365-2222.2007.02742.x. Clin Exp Allergy. 2007. PMID: 17581192 Review.
-
Drug hypersensitivity: insights into pathomechanisms.Eur Ann Allergy Clin Immunol. 2005 Jun;37(6):207-12. Eur Ann Allergy Clin Immunol. 2005. PMID: 16156398 Review.
-
Adverse reactions to drugs: relationship to immunopathic disease.Med J Aust. 1976 Apr 3;1(14):486-8, 490-2. Med J Aust. 1976. PMID: 132598
Cited by
-
Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review.Front Med (Lausanne). 2023 Jun 29;10:1187937. doi: 10.3389/fmed.2023.1187937. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37457584 Free PMC article. Review.
-
Painful and recurring injection site reaction to alirocumab and evolocumab in a young woman with familial hypercholesterolemia and effective therapeutic alternative based on inclisiran: a case report.Front Cardiovasc Med. 2023 Jun 23;10:1181720. doi: 10.3389/fcvm.2023.1181720. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37424909 Free PMC article.
-
Escitalopram Induced Angioedema.Cureus. 2022 Nov 17;14(11):e31600. doi: 10.7759/cureus.31600. eCollection 2022 Nov. Cureus. 2022. PMID: 36540519 Free PMC article.
-
A comprehensive summary of disease variants implicated in metal allergy.J Toxicol Environ Health B Crit Rev. 2022 Aug 18;25(6):279-341. doi: 10.1080/10937404.2022.2104981. Epub 2022 Aug 16. J Toxicol Environ Health B Crit Rev. 2022. PMID: 35975293 Free PMC article. Review.
-
Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole.Microbiol Spectr. 2022 Aug 31;10(4):e0135722. doi: 10.1128/spectrum.01357-22. Epub 2022 Aug 8. Microbiol Spectr. 2022. PMID: 35938810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous